Vivek Durai

3.9k total citations · 1 hit paper
23 papers, 2.6k citations indexed

About

Vivek Durai is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Vivek Durai has authored 23 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Vivek Durai's work include Immunotherapy and Immune Responses (13 papers), T-cell and B-cell Immunology (13 papers) and Immune Cell Function and Interaction (8 papers). Vivek Durai is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), T-cell and B-cell Immunology (13 papers) and Immune Cell Function and Interaction (8 papers). Vivek Durai collaborates with scholars based in United States, Germany and Switzerland. Vivek Durai's co-authors include Kenneth M. Murphy, Carlos G. Briseño, Theresa L. Murphy, Xiaodi Wu, Prachi Bagadia, Gary E. Grajales‐Reyes, Arifumi Iwata, Nicole M. Kretzer, Roxane Tussiwand and Derek J. Theisen and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Vivek Durai

23 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity

2020 356 citations Stephen T. Ferris, Vivek Durai et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vivek Durai United States	19	2.0k	671	630	177	137	23	2.6k
Joseph Larkin United States	25	1.2k 0.6×	539 0.8×	545 0.9×	141 0.8×	136 1.0×	56	2.0k
Rachel Niec United States	13	2.7k 1.4×	594 0.9×	490 0.8×	231 1.3×	164 1.2×	26	3.4k
Jelena S. Bezbradica United States	25	1.6k 0.8×	1.1k 1.7×	342 0.5×	124 0.7×	176 1.3×	45	2.6k
Jacques Deguine United States	16	1.1k 0.5×	490 0.7×	265 0.4×	157 0.9×	176 1.3×	24	1.8k
Xiankui Zhang China	4	2.3k 1.2×	452 0.7×	525 0.8×	279 1.6×	219 1.6×	7	2.9k
Pierre Vantourout United Kingdom	19	2.0k 1.0×	391 0.6×	676 1.1×	68 0.4×	193 1.4×	25	2.5k
Priyanka Sathe Australia	11	2.5k 1.3×	591 0.9×	486 0.8×	113 0.6×	182 1.3×	17	2.9k
Yoshinaga Ito Japan	16	1.6k 0.8×	689 1.0×	556 0.9×	94 0.5×	168 1.2×	27	2.4k
Bas Heinhuis Netherlands	20	1.1k 0.5×	759 1.1×	477 0.8×	87 0.5×	213 1.6×	29	1.9k
Daniel DiToro United States	10	2.1k 1.1×	330 0.5×	397 0.6×	101 0.6×	183 1.3×	16	2.5k

Countries citing papers authored by Vivek Durai

Since Specialization

Citations

This map shows the geographic impact of Vivek Durai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Durai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Durai more than expected).

Fields of papers citing papers by Vivek Durai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Durai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Durai. The network helps show where Vivek Durai may publish in the future.

Co-authorship network of co-authors of Vivek Durai

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek Durai. A scholar is included among the top collaborators of Vivek Durai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek Durai. Vivek Durai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Tiantian, Feiya Ou, Julia A. Belk, et al.. (2023). Cisinteractions in theIrf8locus regulate stage-dependent enhancer activation. Genes & Development. 37(7-8). 291–302. 7 indexed citations

Bowman-Kirigin, Jay A., Rupen Desai, Brian T. Saunders, et al.. (2022). The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain. Cancer Immunology Research. 11(1). 20–37. 24 indexed citations

Durai, Vivek & Rita F. Redberg. (2022). Statin therapy for the primary prevention of cardiovascular disease: Cons. Atherosclerosis. 356. 46–49. 5 indexed citations

Russler‐Germain, Emilie, Jisun Jung, Jaeu Yi, et al.. (2021). Commensal Cryptosporidium colonization elicits a cDC1-dependent Th1 response that promotes intestinal homeostasis and limits other infections. Immunity. 54(11). 2547–2564.e7. 34 indexed citations

Russler‐Germain, Emilie, Jaeu Yi, Katherine Nutsch, et al.. (2021). Gut Helicobacter presentation by multiple dendritic cell subsets enables context-specific regulatory T cell generation. eLife. 10. 24 indexed citations

Ferris, Stephen T., Vivek Durai, Renee Wu, et al.. (2020). cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity. Nature. 584(7822). 624–629. 356 indexed citations breakdown →

Bagadia, Prachi, Xiao Huang, Tiantian Liu, et al.. (2019). An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development. Nature Immunology. 20(9). 1174–1185. 79 indexed citations

Theisen, Derek J., Jesse T. Davidson, Carlos G. Briseño, et al.. (2018). WDFY4 is required for cross-presentation in response to viral and tumor antigens. Science. 362(6415). 694–699. 226 indexed citations

Briseño, Carlos G., Ansuman T. Satpathy, Jesse T. Davidson, et al.. (2018). Notch2-dependent DC2s mediate splenic germinal center responses. Proceedings of the National Academy of Sciences. 115(42). 10726–10731. 56 indexed citations

10.

Durai, Vivek, Prachi Bagadia, Carlos G. Briseño, et al.. (2018). Altered compensatory cytokine signaling underlies the discrepancy between Flt3–/– and Flt3l–/– mice. The Journal of Experimental Medicine. 215(5). 1417–1435. 48 indexed citations

11.

Iwata, Arifumi, Vivek Durai, Roxane Tussiwand, et al.. (2017). Quality of TCR signaling determined by differential affinities of enhancers for the composite BATF–IRF4 transcription factor complex. Nature Immunology. 18(5). 563–572. 88 indexed citations

12.

Durai, Vivek & Kenneth M. Murphy. (2016). Functions of Murine Dendritic Cells. Immunity. 45(4). 719–736. 293 indexed citations

13.

Briseño, Carlos G., Malay Haldar, Nicole M. Kretzer, et al.. (2016). Distinct Transcriptional Programs Control Cross-Priming in Classical and Monocyte-Derived Dendritic Cells. Cell Reports. 15(11). 2462–2474. 152 indexed citations

14.

Murphy, Theresa L., Gary E. Grajales‐Reyes, Xiaodi Wu, et al.. (2016). Transcriptional Control of Dendritic Cell Development. Annual Review of Immunology. 34(1). 93–119. 346 indexed citations

15.

Kretzer, Nicole M., Derek J. Theisen, Roxane Tussiwand, et al.. (2016). RAB43 facilitates cross-presentation of cell-associated antigens by CD8α+ dendritic cells. The Journal of Experimental Medicine. 213(13). 2871–2883. 63 indexed citations

16.

Wu, Xiaodi, Carlos G. Briseño, Vivek Durai, et al.. (2016). Mafb lineage tracing to distinguish macrophages from other immune lineages reveals dual identity of Langerhans cells. The Journal of Experimental Medicine. 213(12). 2553–2565. 93 indexed citations

17.

Grajales‐Reyes, Gary E., Arifumi Iwata, Jörn C. Albring, et al.. (2015). Batf3 maintains autoactivation of Irf8 for commitment of a CD8α+ conventional DC clonogenic progenitor. Nature Immunology. 16(7). 708–717. 269 indexed citations

18.

KC, Wumesh, Ansuman T. Satpathy, Aaron S. Rapaport, et al.. (2014). L-Myc expression by dendritic cells is required for optimal T-cell priming. Nature. 507(7491). 243–247. 62 indexed citations

19.

Layden, Brian T., et al.. (2012). Short chain fatty acids and their receptors: new metabolic targets. Translational research. 161(3). 131–140. 283 indexed citations

20.

Layden, Brian T., Vivek Durai, Alejandra M. Marinelarena, et al.. (2010). Regulation of pancreatic islet gene expression in mouse islets by pregnancy. Journal of Endocrinology. 207(3). 265–279. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact